Veradigm | MDRX - Equity Capital And Reserves


Veradigm reported $1.18B in Equity Capital and Reserves for its fiscal quarter ending in September of 2022.





Equity Capital And Reserves Change Date
Alcidion AUD 87.8M 2.46M Jun/2025
Ambu A/S DKK 6.04B 1000K Dec/2025
Amplifon EUR 970.08M 43.75M Sep/2025
Cardinal Health USD -2.88B 5M Dec/2025
Centene USD 19.95B 995M Dec/2025
Charles River Laboratories USD 3.16B 240.82M Dec/2025
Cigna USD 41.71B 92M Dec/2025
Computer Programs Systems USD 180.36M 7.18M Sep/2025
Convatec Group USD 1.69B 34M Dec/2024
CVS Health USD 75.21B 2.29B Dec/2025
Diasorin EUR 1.53B 151.64M Jun/2025
Elevance Health USD 44.03B 73M Dec/2025
General Electric Aerospace USD 18.9B 86M Dec/2025
Gulf Medical Proj AED 1.22B 132.24M Dec/2025
Humana USD 17.66B 865M Dec/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Laboratory Of America USD 8.62B 93.2M Dec/2025
Maximus USD 1.72B 45.78M Dec/2025
McKesson USD -1.3B 441M Dec/2025
Med Life RON 502.03M 13.72M Sep/2025
Molina Healthcare USD 4.07B 122M Dec/2025
Omnicell USD 1.22B 42.72M Sep/2025
Oriola-kd EUR 117.9M 2.4M Sep/2025
Owens Minor USD -460.98M 31.47M Dec/2025
Quest Diagnostics USD 7.17B 88M Dec/2025
Rede D'or Sao Luiz BRL 28.8B 907.82M Sep/2025
Siemens Healthineers EUR 18.43B 389M Dec/2025
Sonova Holding CHF 2.66B 374.5M Jun/2025
Supermax Corporation Bhd MYR 3.94B 154.28M Sep/2025
UnitedHealth USD 105.81B 1.03B Sep/2025
Veeva Systems USD 7.21B 174.12M Dec/2025
Veradigm USD 1.18B 19.32M Sep/2022
Xerox USD 365M 757M Sep/2025